Annis Gardner Whiting Capital Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.7K | Buy |
47
+36
| +327% | +$18.9K | 0.01% | 531 |
|
|
2025
Q1 | $6.98K | Sell |
11
-6
| -35% | -$3.81K | ﹤0.01% | 589 |
|
|
2024
Q4 | $12.1K | Sell |
17
-20
| -54% | -$14.2K | ﹤0.01% | 510 |
|
|
2024
Q3 | $38.9K | Sell |
37
-16
| -30% | -$16.8K | 0.01% | 392 |
|
|
2024
Q2 | $55.7K | Buy |
53
+10
| +23% | +$10.5K | 0.02% | 386 |
|
|
2024
Q1 | $41.4K | Buy |
43
+11
| +34% | +$10.6K | 0.01% | 412 |
|
|
2023
Q4 | $28.1K | Buy |
32
+1
| +3% | +$878 | 0.01% | 363 |
|
|
2023
Q3 | $25.5K | Buy |
+31
| New | +$25.5K | 0.01% | 364 |
|